ANA
LLUCH HERNANDEZ
EMÉRITO/A UNIVERSIDAD
Institució Catalana de Recerca i Estudis Avançats
Barcelona, EspañaPublicacions en col·laboració amb investigadors/es de Institució Catalana de Recerca i Estudis Avançats (12)
2022
-
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer
Science Advances, Vol. 8, Núm. 20
2021
-
Preclinical and clinical characterization of fibroblast-derived neuregulin-1 on trastuzumab and pertuzumab activity in HER2-positive breast cancer
Clinical Cancer Research, Vol. 27, Núm. 18, pp. 5096-5108
2019
-
A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients
Clinical Epigenetics, Vol. 11, Núm. 1
2018
-
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER + breast cancer
Nature Cell Biology, Vol. 20, Núm. 2, pp. 211-221
-
Erratum to: MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer (Nature Cell Biology, (2018), 20, 2, (211-221), 10.1038/s41556-017-0021-z)
Nature Cell Biology
-
Multicenter phase II study of lurbinectedin in BRCAMutated and unselected metastatic advanced breast cancer and biomarker assessment substudy
Journal of Clinical Oncology, Vol. 36, Núm. 31, pp. 3134-3143
2017
-
Defective cyclin B1 induction in trastuzumab-emtansine (T-DM1) acquired resistance in HER2-positive breast cancer
Clinical Cancer Research, Vol. 23, Núm. 22, pp. 7006-7019
-
Intrinsic subtypes and gene expression profiles in primary and metastatic breast cancer
Cancer Research, Vol. 77, Núm. 9, pp. 2213-2221
2016
-
FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth
Nature Communications, Vol. 7
2015
-
Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis
Journal of the National Cancer Institute, Vol. 107, Núm. 12
-
Patterns of HER2 gene amplification and response to anti-HER2 therapies
PLoS ONE, Vol. 10, Núm. 6
2014
-
Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer
European Journal of Cancer, Vol. 50, Núm. 15, pp. 2725-2734